دورية أكاديمية

PCN94 Cost-Effectiveness of Trifluridine/Tipiracil (FTD/TPI) As a Third-LINE Treatment of Metastatic Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction, Among Patients WHO Have Received at Least Two PRIOR Therapies for Metastatic Disease in Greece

التفاصيل البيبلوغرافية
العنوان: PCN94 Cost-Effectiveness of Trifluridine/Tipiracil (FTD/TPI) As a Third-LINE Treatment of Metastatic Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction, Among Patients WHO Have Received at Least Two PRIOR Therapies for Metastatic Disease in Greece
المؤلفون: Gourzoulidis, G., Koulentaki, M., Koumarianou, A., Samantas, E., Androulakis, N., Xynogalos, S., Papakotoulas, P., Boukovinas, I., Karamouzis, M., Souglakos, I., Chotzagiannoglou, V., Beletsi, A., Kourlaba, G.
المصدر: In Value in Health December 2020 23 Supplement 2:S439-S439
قاعدة البيانات: ScienceDirect
الوصف
تدمد:10983015
DOI:10.1016/j.jval.2020.08.231